| Uptake of active surveillance for very-low-risk prostate cancer in Sweden S Loeb, Y Folkvaljon, C Curnyn, D Robinson, O Bratt, P Stattin JAMA oncology 3 (10), 1393-1398, 2017 | 167 | 2017 |
| Evaluation of the 2015 Gleason grade groups in a nationwide population-based cohort S Loeb, Y Folkvaljon, D Robinson, IF Lissbrant, L Egevad, P Stattin European urology 69 (6), 1135-1141, 2016 | 150 | 2016 |
| Five-year nationwide follow-up study of active surveillance for prostate cancer S Loeb, Y Folkvaljon, DV Makarov, O Bratt, A Bill-Axelson, P Stattin European urology 67 (2), 233-238, 2015 | 106 | 2015 |
| Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer A Vellekoop, S Loeb, Y Folkvaljon, P Stattin The Journal of urology 191 (2), 350-357, 2014 | 106 | 2014 |
| Use of phosphodiesterase type 5 inhibitors for erectile dysfunction and risk of malignant melanoma S Loeb, Y Folkvaljon, M Lambe, D Robinson, H Garmo, C Ingvar, P Stattin Jama 313 (24), 2449-2455, 2015 | 104 | 2015 |
| Testosterone replacement therapy and risk of favorable and aggressive prostate cancer S Loeb, Y Folkvaljon, JE Damber, J Alukal, M Lambe, P Stattin Journal of Clinical Oncology 35 (13), 1430, 2017 | 82 | 2017 |
| Undertreatment of men in their seventies with high-risk nonmetastatic prostate cancer O Bratt, Y Folkvaljon, MH Eriksson, O Akre, S Carlsson, L Drevin, ... European urology 68 (1), 53-58, 2015 | 81 | 2015 |
| Causes of death in men with localized prostate cancer: a nationwide, population‐based study M Van Hemelrijck, Y Folkvaljon, J Adolfsson, O Akre, L Holmberg, ... BJU international 117 (3), 507-514, 2016 | 60 | 2016 |
| Socioeconomic factors and penile cancer risk and mortality; a population‐based study C Torbrand, A Wigertz, L Drevin, Y Folkvaljon, M Lambe, U Håkansson, ... Bju international 119 (2), 254-260, 2017 | 54 | 2017 |
| Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population‐based setting: a report from the Swedish MDS register D Moreno Berggren, Y Folkvaljon, M Engvall, J Sundberg, M Lambe, ... British journal of haematology 181 (5), 614-627, 2018 | 46 | 2018 |
| Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity W Wulaningsih, H Garmo, J Ahlgren, L Holmberg, Y Folkvaljon, A Wigertz, ... Breast cancer research and treatment 172, 167-177, 2018 | 42 | 2018 |
| A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor MP Licciardello, A Ringler, P Markt, F Klepsch, CH Lardeau, S Sdelci, ... Nature chemical biology 13 (7), 771-778, 2017 | 41 | 2017 |
| Adjusted win ratio with stratification: calculation methods and interpretation SB Gasparyan, F Folkvaljon, O Bengtsson, J Buenconsejo, GG Koch Statistical Methods in Medical Research 30 (2), 580-611, 2021 | 38 | 2021 |
| Immediate versus delayed prostatectomy: Nationwide population-based study S Loeb, Y Folkvaljon, D Robinson, DV Makarov, O Bratt, H Garmo, ... Scandinavian journal of urology 50 (4), 246-254, 2016 | 32 | 2016 |
| Meta-analysis of the association between phosphodiesterase inhibitors (PDE5Is) and risk of melanoma S Loeb, E Ventimiglia, A Salonia, Y Folkvaljon, P Stattin JNCI: Journal of the National Cancer Institute 109 (8), djx086, 2017 | 30 | 2017 |
| Phosphodiesterase type 5 inhibitor use and disease recurrence after prostate cancer treatment S Loeb, Y Folkvaljon, D Robinson, T Schlomm, H Garmo, P Stattin European urology 70 (5), 824-828, 2016 | 30 | 2016 |
| Upper limit of cancer extent on biopsy defining very low‐risk prostate cancer O Bratt, Y Folkvaljon, S Loeb, L Klotz, L Egevad, P Stattin BJU international 116 (2), 213-219, 2015 | 30 | 2015 |
| Survival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flap A Svee, M Mani, K Sandquist, T Audolfsson, Y Folkvaljon, AE Isern, ... Journal of British Surgery 105 (11), 1446-1453, 2018 | 28 | 2018 |
| Defining intermediate risk prostate cancer suitable for active surveillance S Loeb, Y Folkvaljon, O Bratt, D Robinson, P Stattin The Journal of Urology 201 (2), 292-299, 2019 | 26 | 2019 |
| Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study U Joneborg, Y Folkvaljon, N Papadogiannakis, M Lambe, L Marions Acta Oncologica 57 (8), 1094-1099, 2018 | 26 | 2018 |
